ARTICLE | Company News
Gilead sales and marketing update
May 4, 2015 7:00 AM UTC
Gilead said that Harvoni ledipasvir/sofosbuvir will now be reimbursed by provincial drug programs in Canadian provinces and territories, excluding Quebec, Prince Edward Island and Newfoundland to tre...